Document is current
Any future updates will be listed below
-
Authors
Barengo, Noël C. http://orcid.org/0000-0003-0660-3091
Apolinar, Leticia Manuel
Estrada Cruz, Norma A.
Fernández Garate, José E.
Correa González, Roberto A.
Diaz Valencia, Paula A.
Gonzalez, Cecilia Alicia Cinco
Rodriguez, José Alberto Gómez
González, Nelly Cisneros
,
Arellano Flores, Maria L.
Ledesma Muñoz, Mercedes E.
Gonzalez Sotelo, Diana A.
Davila Maldonado, Oscar M.
Gomez Garcia, Jhoana G.
Laureano Hernandez, Francisco J.
Jimenez, Julio Eduardo Zarazua
Pulido Garcia, Brenda A.
Vazquez, Hector Rodriguez
Ramirez Dorantes, Alexis A.
Gonzalez Fierro, Liliana A.
Hernandez Hernandez, Juan C.
Perez, Jorge Zenil
-
Funding
Funding for this research was provided by:
Eli Lilly and Company (N/A)
- License Information
-
More Information
Article History
Received: 8 September 2021
Accepted: 16 March 2022
First Online: 4 April 2022
Declarations
:
: The Ethical Committee in Research, Secretaria de Salud, State of Colima-Mexico approved this study: 2021/1/CR/BS/EPI/162, Application. The informed consent form will be obtained from the participants. Whenever a patient is unable to continue the trial, she/he will be excluded from the study. Any modifications to the protocol will be agreed upon and approved by the Ethics Committee prior to implementation and notified to the health authorities in accordance with local regulations.
: Not applicable as we do not publish any individual data.
: The authors declare that they have no competing interests
